Examination of the Psychometric Properties of the Persian Version of the Challenges to Stopping Smoking Scale (CSS) in Patients with Cardiovascular Disease (CVD).
CVD
Challenges to Stopping Smoking
Psychometric evaluation
Smoking
Journal
Tanaffos
ISSN: 1735-0344
Titre abrégé: Tanaffos
Pays: Iran
ID NLM: 101308232
Informations de publication
Date de publication:
Jan 2023
Jan 2023
Historique:
received:
23
01
2022
accepted:
12
06
2022
medline:
3
11
2023
pubmed:
3
11
2023
entrez:
3
11
2023
Statut:
ppublish
Résumé
Smoking is one of the modifiable risk factors for cardiovascular disease (CVD) that is related to different types of chronic disorders. Many patients with CVD consider smoking cessation a difficult task due to various reasons. The goal of the present study was to translate the Challenges to Stopping Smoking Scale (CSS) into Persian and examine its psychometric properties. In this cross-sectional methodological study, a total of 341 patients with CVD [141 for exploratory factor analysis (EFA) and 200 for confirmatory factor analysis (CFA)] participated, and were selected using a convenience sampling method. Participants completed the Persian version of the CSS. Face, content, and construct validities were examined. Internal consistency was assessed using the McDonald's Omega and Cronbach's alpha coefficients, and stability was examined using the test-retest method. In the EFA, two factors of Internal Challenges and External Challenges were extracted that together explained 42.619% of the total variance. Cronbach's alpha coefficients of 0.740 and 0.799 and Intraclass correlation coefficients of 0.862 and 0.869 were found for Internal and External Challenges, respectively. According to the results of CFA, the three-factor model had a good fit to the data. (RMSEA: 0.059; CFI: 0.94; GFI: 0.97; NFI: 0.90; PNFI: 0.77) The Persian version of the CSS has good validity and reliability, and can be used as a valid and reliable instrument in future studies.
Sections du résumé
Background
UNASSIGNED
Smoking is one of the modifiable risk factors for cardiovascular disease (CVD) that is related to different types of chronic disorders. Many patients with CVD consider smoking cessation a difficult task due to various reasons. The goal of the present study was to translate the Challenges to Stopping Smoking Scale (CSS) into Persian and examine its psychometric properties.
Materials and Methods
UNASSIGNED
In this cross-sectional methodological study, a total of 341 patients with CVD [141 for exploratory factor analysis (EFA) and 200 for confirmatory factor analysis (CFA)] participated, and were selected using a convenience sampling method. Participants completed the Persian version of the CSS. Face, content, and construct validities were examined. Internal consistency was assessed using the McDonald's Omega and Cronbach's alpha coefficients, and stability was examined using the test-retest method.
Results
UNASSIGNED
In the EFA, two factors of Internal Challenges and External Challenges were extracted that together explained 42.619% of the total variance. Cronbach's alpha coefficients of 0.740 and 0.799 and Intraclass correlation coefficients of 0.862 and 0.869 were found for Internal and External Challenges, respectively. According to the results of CFA, the three-factor model had a good fit to the data. (RMSEA: 0.059; CFI: 0.94; GFI: 0.97; NFI: 0.90; PNFI: 0.77)
Conclusion
UNASSIGNED
The Persian version of the CSS has good validity and reliability, and can be used as a valid and reliable instrument in future studies.
Types de publication
Journal Article
Langues
eng
Pagination
75-82Informations de copyright
Copyright© 2023 National Research Institute of Tuberculosis and Lung Disease.
Références
Am J Public Health. 2013 Aug;103(8):e59-65
pubmed: 23763395
Int J Environ Res Public Health. 2018 May 18;15(5):
pubmed: 29783678
BMJ Open. 2014 Dec 22;4(12):e006414
pubmed: 25534212
Prim Care. 2018 Mar;45(1):25-44
pubmed: 29406943
J Subst Abuse Treat. 2003 Mar;24(2):169-74
pubmed: 12745034
N Engl J Med. 2012 Jan 26;366(4):321-9
pubmed: 22276822
Eur J Prev Cardiol. 2015 Sep;22(9):1212-9
pubmed: 25516535
J Nurs Scholarsh. 2001;33(4):355-9
pubmed: 11775306
J Psychiatr Ment Health Nurs. 2005 Dec;12(6):672-8; quiz 678
pubmed: 16336591
Arch Iran Med. 2017 Apr;20(4):229-234
pubmed: 28412827
Soc Sci Med. 1995 Nov;41(10):1403-9
pubmed: 8560308
Birth. 2013 Sep;40(3):202-8
pubmed: 24635505
BMJ Open. 2016 Mar 31;6(3):e011265
pubmed: 27033963
Br J Psychol. 2014 Aug;105(3):399-412
pubmed: 24844115
Nurs Res. 1995 Jul-Aug;44(4):214-9
pubmed: 7624231
JAMA. 2014 Jan 8;311(2):183-92
pubmed: 24399557
Lancet. 2012 Aug 18;380(9842):668-79
pubmed: 22901888
BMJ. 2018 Jan 24;360:j5855
pubmed: 29367388
Eur J Epidemiol. 2016 Dec;31(12):1191-1205
pubmed: 27699514
Public Health Nurs. 1995 Apr;12(2):117-26
pubmed: 7739982
Addiction. 2011 Apr;106(4):716-28
pubmed: 21205053
Addict Behav. 2005 Mar;30(3):423-35
pubmed: 15718060
Circulation. 2017 Mar 7;135(10):e146-e603
pubmed: 28122885
Open Heart. 2016 Jul 12;3(2):e000358
pubmed: 27493759